A study to assess the efficacy of enasidenib and risk-adapted addition of azacitidine in newly diagnosed IDH2-mutant AML
Titel:
A study to assess the efficacy of enasidenib and risk-adapted addition of azacitidine in newly diagnosed IDH2-mutant AML
Auteur:
Cai, Sheng F. Huang, Ying Lance, Jennie R. Mao, Hsiaoyin Charlene Dunbar, Andrew J. McNulty, Samantha N. Druley, Todd Li, Yan Baer, Maria R. Stock, Wendy Kovacsovics, Tibor Blum, William G. Schiller, Gary J. Olin, Rebecca L. Foran, James M. Litzow, Mark Lin, Tara Patel, Prapti Foster, Matthew C. Boyiadzis, Michael Collins, Robert H. Chervin, Jordan Shoben, Abigail Vergilio, Jo-Anne Heerema, Nyla A. Rosenberg, Leonard Chen, Timothy L. Yocum, Ashley O. Druggan, Franchesca Marcus, Sonja Stefanos, Mona Druker, Brian J. Mims, Alice S. Borate, Uma Burd, Amy Byrd, John C. Levine, Ross L. Stein, Eytan M.